Skip to main content

Day: January 8, 2026

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

‒ Q4 2025 Unaudited Net Revenue of Approximately $127 million ‒ ‒ FY 2025 Unaudited Pro Forma Net Revenue of Approximately $400 million ‒ ‒ Expects Q4 Adjusted EBITDA of Between $77 million and $81 million ‒ ‒ Unaudited Cash and Short-term Investments of Approximately $148 million ‒   BERKELEY HEIGHTS, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) — CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces its preliminary unaudited fourth quarter 2025 and full-year 2025 results, and provides guidance and an update on its business. These include the following key updates:CorMedix announces preliminary, unaudited financial results for Q4 and FY 2025, including net revenue of approximately $127 million and...

Continue reading

AGF Investments Launches ETF Series for Legacy Funds: AGF American Growth Fund and AGF Global Select Fund

Offerings provide investors with access to capabilities in their preferred vehicle TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) announced today the launch of ETF series units for AGF American Growth Fund and AGF Global Select Fund, providing investors with access to legacy funds with long-standing, proven track records in an ETF series. “This launch expands our ETF lineup and responds directly to growing investor demand for more choice in how they access our capabilities,” said Meaghan Kelly, Chief Marketing & Product Officer, AGF Investments. “By offering these well-established funds in an ETF series option, we’re ensuring investors can engage with our strategies in the vehicle that best suits their needs.”Fund Fund Series Available ETF Series Ticker Risk RatingAGF American Growth...

Continue reading

Public Affairs, Reputation and Issues Management Expert Joshua Baca Joins FTI Consulting

WASHINGTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Joshua Baca as a Senior Managing Director. Mr. Baca, who is based in Washington, D.C., joins FTI Consulting’s Strategic Communications segment with more than 20 years of experience at the intersection of government, business and reputation. In his role at FTI Consulting, he will advise on stakeholder engagement and advocacy campaigns to help client organizations manage change, mitigate risk and advance business opportunities. “Joshua has a proven track record of helping businesses and industry groups navigate challenges and advance their objectives through impactful integrated strategic communications campaigns,” said Mateo Millett, a Senior Managing Director and Global Head of the Industrials Sector in the Strategic Communications...

Continue reading

Beneficient Enters into $3 Million GP Primary Capital Transaction

DALLAS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of an approximately $3 million primary capital commitment for Cork & Vines Fund I, LP (“Fund”), a fund managed by Cork & Vines GP, LP, an asset manager investing in opportunities within the premium experiential, luxury dining segment with a differentiated culinary and strategic wine program focus. The transaction follows the Company’s initial GP Primary Capital transaction with Cork & Vines that closed in early 2025. In exchange for an interest in the Fund, the Fund received approximately $3 million in stated value...

Continue reading

GURU Organic Energy to Report Fourth Quarter and Fiscal Year 2025 Results

MONTRÉAL, Jan. 08, 2026 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand1, will report its financial results for the fourth quarter and fiscal year ended October 31, 2025 on Thursday, January 22, 2026, before markets open. Management will hold a conference call to discuss its financial results the same day at 10:00 a.m. ET. The conference call will include a Q&A period open exclusively to financial analysts who are invited to participate by using the dial-in number provided below. Other interested parties are invited to participate in the call on a listen-only basis and are encouraged to do so via live audio webcast, which will be available on GURU’s website. Conference call and webcast details:Thursday, January 22, 2026, at 10:00 a.m. ET Via...

Continue reading

Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 44th Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 12th, 2026, at 4:30 p.m. PST (7:30 p.m. EST). A link to the live audio webcast, as well as a copy of the accompanying presentation slides and a replay of this event, will be available on the company’s website (www.enovis.com) at Events and Presentations.       About Enovis Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We partner with the brightest minds in health...

Continue reading

Dragonfly Energy Issues Year-End CEO Letter to Shareholders

RENO, Nev., Jan. 08, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage, today issued a Year-End Letter to Shareholders from its Chief Executive Officer and President, Dr. Denis Phares. Dear DFLI Shareholders, 2025 marked an important inflection point in Dragonfly Energy’s history. We greatly improved our balance sheet, expanded our OEM footprint, and secured critical validation in heavy-duty trucking, including a commercial deployment from Werner Enterprises following a successful real-world pilot of our advanced idle-reduction power systems. These achievements helped us return to year-over-year revenue growth and position us to execute on the vision that drove us to become a public company three years ago. The mission and strategy...

Continue reading

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference

CELEBRATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco, CA on Thursday, January 15, 2026, at 9:45 a.m. PT. Additionally, management will be available for one-on-one meetings with registered conference attendees. A link to the live webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website at investors.zevra.com. About Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. is a purpose-driven, commercial-stage company focused on bringing life-changing therapeutics to people...

Continue reading

Electra Provides Update on Refinery Project Progress

TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in advancing North America’s critical minerals processing, is pleased to provide an update on construction progress at North America’s first cobalt sulfate refinery. “Momentum continues to build across the project,” said Paolo Toscano, VP Projects and Engineering. “Strong planning and close collaboration with our partners are translating into tangible progress on the ground. We are excited by how the project is coming together and remain fully focused on delivering this important facility efficiently and safely.”Construction crews recently completed the installation of exterior pipe racks which will connect the leach plant, solvent extraction (SX) building, and crystallizer. Current...

Continue reading

North American Niobium and Critical Minerals Corp. Reports Positive Preliminary Soil-Gas Radon Survey Results at Blanchette and Bardy; Phase 2 Planned with Rapid Follow-Up Portable Bedrock Drilling Program

Vancouver, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — North America Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“North American Niobium” or the “Company”) is pleased to provide an update on its Phase 1 soil-gas radon survey completed by RadonEx on the Company’s Blanchette and Bardy properties in Québec, located approximately 40 km northwest of the Municipality of La Tuque. Preliminary results are positive, with multiple anomalous zones (“radon hot spots”) observed that are spatially associated with the REE mineral prospects Blanchette-1, Blanchette-2 and Bardy, and that may suggest additional target areas are consistent with extensions of REE-bearing pegmatitic granitic dykes. HighlightsMultiple preliminary anomalous zones appear spatially associated with Blanchette-1, Blanchette-2 and Bardy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.